B. Dahlbäck

B. Dahlbäck, J. Sundquist, K. Sundquist, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Gas6‐Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor‐progressive advantages

B. Dahlbäck, A. Gustafsson, H. Fritz, 2017, Experimental cell research.

Erythrocyte-Derived Microparticles Supporting Activated Protein C-Mediated Regulation of Blood Coagulation

B. Dahlbäck, E. Norström, Sofia Somajo, 2014, PloS one.

Viability of a marine microbial biofilm

B. Dahlbäck, K. Pedersen, 1982, Current Microbiology.

The tale of protein S and C4b-binding protein, a story of affection

B. Dahlbäck, 2007, Thrombosis and Haemostasis.

Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood

B. Dahlbäck, J. Stenhoff, C. Ekman, 2010, Journal of thrombosis and haemostasis : JTH.

Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts.

B. Dahlbäck, J. Stenhoff, S. Hafizi, 2004, Biochemical and biophysical research communications.

Carriership of Factor V Leiden and evolutionary selection advantage.

B. Dahlbäck, P. Lindqvist, 2008, Current medicinal chemistry.

Improved Hemoglobin Status and Reduced Menstrual Blood Loss among Female Carriers of Factor V Leiden – An Evolutionary Advantage?

B. Dahlbäck, Bengt Zöller, P. Lindqvist, 2001, Thrombosis and Haemostasis.

Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue.

B. Dahlbäck, H. Morris, M. Panico, 2011, Blood.

Human activated protein C variants in a rat model of arterial thrombosis

K. Malm, B. Dahlbäck, B. Arnljots, 2008, Thrombosis journal.

Antithrombotic and anticoagulant effects of wild type and Gla-domain mutated human activated protein C in rats.

K. Malm, B. Dahlbäck, I. Persson, 2007, Thrombosis research.

Enhancement of Human Protein C Function by Site-directed Mutagenesis of the γ-Carboxyglutamic Acid Domain*

B. Dahlbäck, L. Shen, G. Nelsestuen, 1998, The Journal of Biological Chemistry.

Enhancing the activity of protein C by mutagenesis to improve the membrane-binding site: studies related to proline-10.

B. Dahlbäck, L. Shen, G. Nelsestuen, 1997, Biochemistry.

Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site.

W. Kisiel, B. Dahlbäck, G. Nelsestuen, 1997, Biochemistry.

Molecular cloning, expression and functional characterization of rabbit anticoagulant vitamin-K-dependent protein S.

B. Dahlbäck, X. He, 1993, European journal of biochemistry.

Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles.

B. Dahlbäck, P. Sims, T. Wiedmer, 1992, Biochemistry.

Vitamin K-Dependent Protein S Localizing Complement Regulator C4b-Binding Protein to the Surface of Apoptotic Cells

A. Blom, B. Dahlbäck, J. Webb, 2002 .

Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.

B. Dahlbäck, 1994, The Journal of clinical investigation.

Thrombotic risk during pregnancy: a population study.

K. Maršál, B. Dahlbäck, P. Lindqvist, 1999, Obstetrics and gynecology.

Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.

B. Dahlbäck, J. Sundquist, K. Sundquist, 2014, Thrombosis research.

A Common 4G Allele in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene as a Risk Factor for Pulmonary Embolism and Arterial Thrombosis in Hereditary Protein S Deficiency

B. Dahlbäck, P. García de Frutos, Bengt Zöller, 1998, Thrombosis and Haemostasis.

Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus

G. Sturfelt, B. Dahlbäck, A. Bengtsson, 1996, Lupus.

A Novel Interaction Between Type IV Pili of Neisseria gonorrhoeae and the Human Complement Regulator C4b-Binding Protein1

A. Blom, G. Lindahl, B. Dahlbäck, 2001, The Journal of Immunology.

The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues.

H. Lilja, B. Dahlbäck, J. Malm, 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Actuated protein C resistance: From phenotype to genotype and clinical practice

B. Dahlbäck, Bengt Zöller, A. Hillarp, 1995 .

Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa.

B. Dahlbäck, J. Stenflo, 2005, European journal of biochemistry.

Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection.

B. Dahlbäck, H. Ekberg, P. Svensson, 2000, Transplantation.

HEMATOPOIESIS Cleavage of Factor V at Arg 506 by Activated Protein C and the Expression of Anticoagulant Activity of Factor

R. Kaufman, B. Dahlbäck, E. Thorelli, 1999 .

Activated protein C resistance caused by a common factor V mutation has a single origin.

B. Dahlbäck, Bengt Zöller, A. Hillarp, 1997, Thrombosis research.

Resistance to activated protein C, the FV : Q506 allele, and venous thrombosis

B. Dahlbäck, A. Hillarp, B. Zöller, 1996, Annals of Hematology.

Inherited resistance to activated protein C and venous thrombosis

B. Dahlbäck, Bengt Zöller, 1996 .

Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits.

B. Dahlbäck, B. Arnljots, 1995, The Journal of clinical investigation.

Thromboembolic Disease – Critical Evaluation of Laboratory Investigation

B. Dahlbäck, J. Malm, I. Nilsson, 1992, Thrombosis and Haemostasis.

Primary structure of bovine vitamin K-dependent protein S.

B. Dahlbäck, J. Stenflo, Å. Lundwall, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives.

B. Dahlbäck, M. Hellgren, P. Svensson, 1995, American journal of obstetrics and gynecology.

Platelet Factor 4 Impairs the Anticoagulant Activity of Activated Protein C*

B. Dahlbäck, B. White, Jennifer A. Johnson, 2009, Journal of Biological Chemistry.

Effects of Factor Xa and Protein S on the Individual Activated Protein C-mediated Cleavages of Coagulation Factor Va*

B. Dahlbäck, M. Steen, S. Tran, 2006, Journal of Biological Chemistry.

Use of Selective Factor V Leiden Screening in Pregnancy to Identify Candidates for Anticoagulants

B. Dahlbäck, P. Olofsson, P. Lindqvist, 2002, Obstetrics and gynecology.

Symposium in memory of Professor Inga Marie Nilsson

M. Blombäck, P. Mannucci, J. Astermark, 2001 .

Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms.

B. Dahlbäck, 1999, The Journal of laboratory and clinical medicine.

Myocardial infarction associated with homozygous resistance to activated protein C

B. Dahlbäck, E. Berntorp, P. Svensson, 1994, The Lancet.

Evaluation of Original and Modified APC-Resistance Tests in Unselected Outpatients with Clinically Suspected Thrombosis and in Healthy Controls

B. Dahlbäck, P. Svensson, Bengt Zöller, 1997, Thrombosis and Haemostasis.

Multicenter Evaluation of a Kit for Activated Protein C Resistance on Various Coagulation Instruments Using Plasmas from Healthy Individuals

B. Dahlbäck, S. Rosén, K. Johansson, 1994, Thrombosis and Haemostasis.

Anti‐factor V auto‐antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding

B. Dahlbäck, É. Ajzner, I. Balogh, 2003, Journal of thrombosis and haemostasis : JTH.

Binding of bovine coagulation factor Xa to platelets.

B. Dahlbäck, J. Stenflo, 1978, Biochemistry.

Ligand Recognition and Homophilic Interactions in Tyro3 STRUCTURAL INSIGHTS INTO THE Axl/Tyro3 RECEPTOR TYROSINE KINASE FAMILY*

B. Dahlbäck, Y. Muller, C. Heiring, 2004 .

The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles*

B. Dahlbäck, M. Mörgelin, Kaisa E. Happonen, 2016, The Journal of Biological Chemistry.

1 The Gas 6-Axl interaction mediates endothelial uptake of platelet microparticles

B. Dahlbäck, M. Mörgelin, Kaisa E. Happonen, 2022 .

Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.

B. Dahlbäck, E. Norström, Sofia Somajo, 2014, Thrombosis research.

associated with thrombosis Functional characterization of factor V-Ile359Thr: a novel mutation

B. Dahlbäck, A. Mumford, E. Tuddenham, 2013 .

Human coagluation factor V purification and thrombin-catalyzed activation.

B. Dahlbäck, 1980, Journal of Clinical Investigation.

The activation of prothrombin by platelet-bound factor Xa.

B. Dahlbäck, J. Stenflo, 1980, European journal of biochemistry.

Protein structural requirements and properties of membrane binding by gamma-carboxyglutamic acid-containing plasma proteins and peptides.

W. Kisiel, B. Dahlbäck, D. Stern, 1989, The Journal of biological chemistry.

Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury.

K. Malm, B. Dahlbäck, B. Arnljots, 2003, Plastic and reconstructive surgery.

Tissue vitronectin in normal adult human dermis is non-covalently bound to elastic tissue.

B. Dahlbäck, M. Pepys, H. Hintner, 1991, The Journal of investigative dermatology.

Prothrombin Activation in the Presence of Platelets

B. Dahlbäck, J. Stenflo, 1979 .

Vitronectin shows complement-independent binding to isolated keratin filament aggregates.

B. Dahlbäck, U. Stanzl, H. Hintner, 1989, The Journal of investigative dermatology.

Assignment of gene for coagulation factor V to chromosome 1 in man and to chromosome 13 in rat

B. Dahlbäck, Mozaffarul Islam, G. Levan, 1988, Somatic cell and molecular genetics.

New Molecular Insights into the Genetics of Thrombophilia. Resistance to Activated Protein C Caused by Arg506 to Gin Mutation in Factor V as a Pathogenic Risk Factor for Venous Thrombosis

B. Dahlbäck, 1995, Thrombosis and Haemostasis.

Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases

L. Björck, B. Dahlbäck, H. Herwald, 1998, Nature Medicine.

Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.

B. Dahlbäck, Maria F. Gomez, J. Swinny, 2010, The international journal of biochemistry & cell biology.

Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives.

B. Dahlbäck, M. Hellgren, P. Svensson, 1995, American journal of obstetrics and gynecology.

Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.

B. Dahlbäck, X. He, L. Shen, 1997, Thrombosis and haemostasis.

Umbilical cord plasma levels of growth‐arrest specific protein 6 in intrauterine growth restriction

B. Dahlbäck, P. Lindqvist, I. Balogh, 2010, Acta obstetricia et gynecologica Scandinavica.

Factor V Leiden in pregnancies complicated by placental abruption

K. Maršál, B. Dahlbäck, M. Procházka, 2003, BJOG : an international journal of obstetrics and gynaecology.

Individual risk assessment of thrombosis in pregnancy

B. Dahlbäck, P. Lindqvist, M. Kublikas, 2002, Acta obstetricia et gynecologica Scandinavica.

Plasma levels of apolipoprotein M in normal and complicated pregnancy

B. Dahlbäck, P. Lindqvist, J. Ahnström, 2010, Acta obstetricia et gynecologica Scandinavica.

Inhibition of Microarterial Thrombosis by Activated Protein C in a Rabbit Model

B. Dahlbäck, D. Bergqvist, B. Arnljots, 1994, Thrombosis and Haemostasis.

Altered inactivation pathway of factor Va by activated protein C in the presence of heparin.

B. Dahlbäck, B. Villoutreix, G. Nicolaes, 2004, European journal of biochemistry.

Interspecies Loop Grafting in the Protease Domain of Human Protein C Yielding Enhanced Catalytic and Anticoagulant Activity

B. Dahlbäck, B. Villoutreix, L. Shen, 1999, Thrombosis and Haemostasis.

Involvement of Lys 62[217] and Lys 63[218] of Human Anticoagulant Protein C in Heparin Stimulation of Inhibition by the Protein C Inhibitor

B. Dahlbäck, B. Villoutreix, L. Shen, 1999, Thrombosis and Haemostasis.

Cleavage requirements for activation of factor V by factor Xa.

R. Kaufman, B. Dahlbäck, E. Thorelli, 1997, European journal of biochemistry.

Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin.

B. Dahlbäck, R. Karlsson, S. Hafizi, 2002, Biochemical and biophysical research communications.

Protein S and C4b-Binding Protein: Components Involved in the Regulation of the Protein C Anticoagulant System

B. Dahlbäck, 1991, Thrombosis and Haemostasis.

Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized.

B. Dahlbäck, B. Villoutreix, M. Miteva, 2003, Blood.

The protein C anticoagulant system: inherited defects as basis for venous thrombosis.

B. Dahlbäck, 1995, Thrombosis research.

Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation.

B. Dahlbäck, G. Nicolaes, J. Rosing, 2008, Blood.

Coagulation factor VA 2440 G causes east Texas bleeding disorder via TFPI alpha

D. Milewicz, B. Dahlbäck, L. Vincent, 2013 .

Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation.

B. Dahlbäck, J. Griffin, E. Podack, 1986, The Journal of biological chemistry.

Immunohistochemical demonstration of vitronectin in association with elastin and amyloid deposits in human kidney

B. Dahlbäck, K. Dahlbäck, H. Löfberg, 2004, Histochemistry.

Immunohistochemical demonstration of age-related deposition of vitronectin (S-protein of complement) and terminal complement complex on dermal elastic fibers.

B. Dahlbäck, J. Alumets, K. Dahlbäck, 1989, The Journal of investigative dermatology.

Fibrillin immunoreactive fibers constitute a unique network in the human dermis: immunohistochemical comparison of the distributions of fibrillin, vitronectin, amyloid P component, and orcein stainable structures in normal skin and elastosis.

E. Engvall, B. Dahlbäck, L. Sakai, 1990, The Journal of investigative dermatology.

Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma

L. Björck, B. Dahlbäck, H. Herwald, 2003, Journal of thrombosis and haemostasis : JTH.

Protein C, Protein S and c4b-Binding Protein in Severe lnfection and Septic Shock

M. Blombäck, B. Dahlbäck, J. Malm, 1991, Thrombosis and Haemostasis.

Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism.

B. Dahlbäck, 1995, Blood.

Inherited Thrombophilia: Part 1

P. Mannucci, F. Rosendaal, J. Miletich, 1996, Thrombosis and Haemostasis.

Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin.

B. Dahlbäck, 1983, The Biochemical journal.

Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients.

B. Dahlbäck, E. Berntorp, I. Nilsson, 1990, Blood.

Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients.

B. Dahlbäck, E. Berntorp, I. Nilsson, 1990, Blood.

Inhibition of platelet prothrombinase activity by a lupus anticoagulant.

B. Dahlbäck, B. Frohm, I. Nilsson, 1983, Blood.

Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.

B. Dahlbäck, E. Berntorp, Bengt Zöller, 1997, Annual review of medicine.

Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.

B. Dahlbäck, X. He, P. Svensson, 1994, The Journal of clinical investigation.

Changes in the plasma levels of vitamin K‐dependent proteins C and S and of C4b‐binding protein during pregnancy and oral contraception

B. Dahlbäck, J. Malm, M. Laurell, 1988, British journal of haematology.

Gla domain-mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding.

B. Dahlbäck, Lei Shen, Björn Dahlbäck, 2003, Blood.

Expression of completely γ‐carboxylated and β‐hydroxylated recombinant human vitamin‐K‐dependent protein S with full biological activity

B. Dahlbäck, J. Malm, E. Cohen, 1990 .

Defining the Factor Xa-binding Site on Factor Va by Site-directed Glycosylation*

B. Dahlbäck, B. Villoutreix, T. Yamazaki, 2002, The Journal of Biological Chemistry.

Cleavage Requirements of Factor V in Tissue-factor Induced Thrombin Generation

R. Kaufman, B. Dahlbäck, E. Thorelli, 1998, Thrombosis and Haemostasis.

Structural investigation of the A domains of human blood coagulation factor V by molecular modeling

B. Dahlbäck, B. Villoutreix, 1998, Protein science : a publication of the Protein Society.

An Arg545→ Cys545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease

B. Dahlbäck, I. Nilsson, L. Holmberg, 1991, European journal of haematology.

Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine.

B. Dahlbäck, G. Nelsestuen, J. Coe, 1992, Biochemistry.

Isolation of human tyrosinase from cultured melanoma cells.

B. Dahlbäck, E. Rosengren, H. Rorsman, 1989, Acta dermato-venereologica.

The nanoparticle protein corona formed in human blood or human blood fractions

B. Dahlbäck, S. Linse, T. Cedervall, 2017, PloS one.

SHBG region of the anticoagulant cofactor protein S: Secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations

P. Fernlund, B. Dahlbäck, B. Villoutreix, 1997, Proteins.

HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation

R. Proia, S. Swendeman, B. Dahlbäck, 2015, Science Signaling.

The anticoagulant protein C pathway

B. Dahlbäck, B. Villoutreix, 2005, FEBS letters.

Epidemiology of Familial Aggregation of Venous Thromboembolism

B. Dahlbäck, J. Sundquist, K. Sundquist, 2016, Seminars in Thrombosis and Hemostasis.

Advances in understanding pathogenic mechanisms of thrombophilic disorders.

B. Dahlbäck, 2008, Blood.

Thrombophilia as a multigenic disease.

B. Dahlbäck, P. García de Frutos, Bengt Zöller, 1999, Haematologica.

Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S.

B. Dahlbäck, P. García de Frutos, Bengt Zöller, 1995, Blood.

Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes.

B. Dahlbäck, D. Lane, H. Ireland, 1997, Blood.

Genes for C4b-binding protein α- and β-chains (C4BPA andC4BPB) are located on chromosome 1, band 1q32, in humans and on chromosome 13 in rats

B. Dahlbäck, G. Levan, C. Szpirer, 1990, Somatic cell and molecular genetics.

A Novel Human Apolipoprotein (apoM)*

B. Dahlbäck, N. Xu, 1999, The Journal of Biological Chemistry.

The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.

D. Lindgren, B. Dahlbäck, H. Axelson, 2014, European journal of cancer.

Two new candidate mutations in type IIA von Willebrand's disease (ARG834→GLY, GLY846→ARG) and one polymorphism (TYR821→CYS) in the A2 region of the von Willebrand factor

B. Dahlbäck, E. Berntorp, E. Scheibel, 1993, European journal of haematology.

An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA

L. Groop, P. Almgren, T. Tuomi, 2010, Journal of internal medicine.

The Ran binding protein RanBPM interacts with Axl and Sky receptor tyrosine kinases.

B. Dahlbäck, A. Gustafsson, J. Stenhoff, 2005, The international journal of biochemistry & cell biology.

Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma

B. Dahlbäck, H. Axelson, B. Ljungberg, 2009, PloS one.

Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.

B. Dahlbäck, S. Hafizi, 2006, Cytokine & growth factor reviews.

Plasma concentrations of apolipoproteins A-I, B and M in patients with abdominal aortic aneurysms.

B. Dahlbäck, A. Gottsäter, B. Lindblad, 2010, Clinical biochemistry.

Gas6 and protein S

B. Dahlbäck, S. Hafizi, 2006, The FEBS journal.

Ligand Recognition and Homophilic Interactions in Tyro3

B. Dahlbäck, Y. Muller, C. Heiring, 2004, Journal of Biological Chemistry.

Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.

B. Dahlbäck, 1997, Seminars in hematology.

Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.

B. Dahlbäck, Bengt Zöller, A. Hillarp, 1996, Haemostasis.

Differential Expression of Axl and Gas6 in Renal Cell Carcinoma Reflecting Tumor Advancement and Survival

B. Dahlbäck, B. Ljungberg, A. Gustafsson, 2009, Clinical Cancer Research.

Tensin3 Is a Negative Regulator of Cell Migration and All Four Tensin Family Members Are Downregulated in Human Kidney Cancer

Börje Ljungberg, Göran Landberg, B. Dahlbäck, 2009, PloS one.

Structural investigation of C4b‐binding protein by molecular modeling: Localization of putative binding sites

D. Covell, A. Wallqvist, B. Dahlbäck, 1998, Proteins.

Sphingosine 1‐phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons

B. Dahlbäck, Cecilia Frej, F. Taylor, 2016, Journal of cellular and molecular medicine.

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

B. Dahlbäck, Y. Muller, T. Hla, 2011, Proceedings of the National Academy of Sciences.

Apolipoprotein M associates to lipoproteins through its retained signal peptide

B. Dahlbäck, J. Ahnström, O. Axler, 2008, FEBS letters.

Biocompatibility of mannan nanogel--safe interaction with plasma proteins.

Sílvia A. Ferreira, F. M. Gama, B. Dahlbäck, 2012, Biochimica et biophysica acta.

The C-terminal Region of the Factor V B-domain Is Crucial for the Anticoagulant Activity of Factor V*

R. Kaufman, B. Dahlbäck, E. Thorelli, 1998, The Journal of Biological Chemistry.

Protein S secretion differences of missense mutants account for phenotypic heterogeneity.

B. Dahlbäck, Y. Espinosa-Parrilla, N. Sala, 2000, Blood.

TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

B. Dahlbäck, S. Rezende, D. Lane, 2014, Blood.

activated protein C-catalyzed factor Va-inactivation Re-evaluation of the role of the protein S-C4b binding protein complex in

B. Dahlbäck, G. Nicolaes, J. Rosing, 2013 .

C4b-binding protein (C4BP) beta-chain Short Consensus Repeat-2 specifically contributes to the interaction of C4BP with protein S.

B. Dahlbäck, J. Meijers, B. Bouma, 1999, Blood cells, molecules & diseases.

Resistance to Activated Protein C Caused by the Factor V R506Q Mutation ls a Common Risk Factor for Venous Thrombosis

B. Dahlbäck, B Dahlbäck, 1997, Thrombosis and Haemostasis.

An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma Published, JLR Papers in Press, May 25, 2007.

B. Dahlbäck, J. Ahnström, O. Axler, 2007, Journal of Lipid Research.

Structural and Energetic Characteristics of the Heparin-binding Site in Antithrombotic Protein C*

A. Blom, B. Dahlbäck, B. Villoutreix, 2001, The Journal of Biological Chemistry.

Bleeding Complications Associated with Low Molecular Weight Heparin Prophylaxis during Pregnancy

B. Dahlbäck, P. Lindqvist, 2000, Thrombosis and Haemostasis.

High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein.

B. Dahlbäck, J. Stenflo, B. Dahlback, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Interaction Between Vitamin K-Dependent Protein S and the Complement Protein, C4b-Binding Protein

B. Dahlbäck, 1984, Seminars in thrombosis and hemostasis.

Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S.

B. Dahlbäck, P. García de Frutos, Bengt Zöller, 1994, Blood.

HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium

B. Dahlbäck, Mario Ruiz, Hiromi Okada, 2017, Lipids in Health and Disease.

Clarification of the Risk for Venous Thrombosis Associated with Hereditary Protein S Deficiency by Investigation of a Large Kindred with a Characterized Gene Defect

B. Dahlbäck, P. García de Frutos, D. Lane, 1998, Annals of Internal Medicine.

Multicentre Evaluation of IL Test™ Free PS: A Fully Automated Assay to Quantify Free Protein S

B. Dahlbäck, E. Rossi, M. Borrell, 2002, Thrombosis and Haemostasis.

Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states.

B. Dahlbäck, G. Nicolaes, 2003, Hematology/oncology clinics of North America.

Molecular genetics of thrombophilia: factor V gene mutation causing resistance to activated protein C as a basis of the hypercoagulable state.

B. Dahlbäck, 1995, The Journal of laboratory and clinical medicine.

Factor V and Thrombotic Disease: Description of a Janus-Faced Protein

B. Dahlbäck, G. Nicolaes, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Antithrombotic effects of activated protein C and protein S in a rabbit model of microarterial thrombosis.

B. Dahlbäck, B. Arnljots, B. Dahlbäck, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Chapter 9B Inhibitors: protein C

P. Fernlund, B. Dahlbäck, J. Stenflo, 1986 .

Novel type of very high affinity calcium-binding sites in beta-hydroxyasparagine-containing epidermal growth factor-like domains in vitamin K-dependent protein S.

B. Dahlbäck, S. Linse, B. Hildebrand, 1990, The Journal of biological chemistry.

Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation.

B. Dahlbäck, E. Cohen, J. Stenflo, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease.

B. Dahlbäck, P. García de Frutos, Bengt Zöller, 1995, Blood.

Interaction between complement component C4b-binding protein and the vitamin K-dependent protein S. A link between blood coagulation and the complement system.

B. Dahlbäck, 1985, Scandinavian journal of clinical and laboratory investigation. Supplementum.

Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes.

B. Dahlbäck, G. Nelsestuen, R. Schwalbe, 1990, The Journal of biological chemistry.

High affinity interaction between C4b-binding protein and vitamin K-dependent protein S in the presence of calcium. Suggestion of a third component in blood regulating the interaction.

B. Dahlbäck, G. Nelsestuen, B. Frohm, 1990, The Journal of biological chemistry.

Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH

R. Marlar, B. Dahlbäck, J. Ahnström, 2021, Journal of thrombosis and haemostasis : JTH.

A Region of Vitamin K-dependent Protein S That Binds to C4b Binding Protein (C4BP) Identified Using Bacteriophage Peptide Display Libraries*

David A. Schultz, B. Dahlbäck, S. Linse, 1997, The Journal of Biological Chemistry.

The preAR2 region (1458–1492) in factor V‐Short is crucial for the synergistic TFPIα‐cofactor activity with protein S and the assembly of a trimolecular factor Xa‐inhibitory complex comprising FV‐Short, protein S, and TFPIα

B. Dahlbäck, S. Tran, 2021, Journal of thrombosis and haemostasis : JTH.

New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV‐Short

B. Dahlbäck, Bengt Zöller, S. Tran, 2019, Journal of thrombosis and haemostasis : JTH.

Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain.

B. Dahlbäck, S. Rezende, D. Lane, 2010, Blood.

Structural Requirements of Anticoagulant Protein S for Its Binding to the Complement Regulator C4b-binding Protein*

Sara Linse, Bruno O. Villoutreix, B. Dahlbäck, 2002, The Journal of Biological Chemistry.

Three‐dimensional model of the SHBG‐like region of anticoagulant protein S: New structure–function insights

B. Dahlbäck, B. Villoutreix, Y. Muller, 2001, Proteins.

Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein.

B. Dahlbäck, S. Linse, P. García de Frutos, 1999, European journal of biochemistry.

Ultrastructure of C4b-binding protein fragments formed by limited proteolysis using chymotrypsin.

B. Dahlbäck, H. Müller-Eberhard, 1984, The Journal of biological chemistry.

Plasma concentrations of C4b‐binding protein and vitamin K‐dependent protein S in term and preterm infants: low levels of protein S‐C4b‐binding protein complexes

B. Dahlbäck, J. Malm, L. Holmberg, 1988, British journal of haematology.

Localization of vitronectin (S-protein of complement) in normal human skin.

B. Dahlbäck, K. Dahlbäck, H. Löfberg, 1986, Acta dermato-venereologica.

Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase.

A. Blom, B. Dahlbäck, A. Zadura, 2000, Molecular immunology.

Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?

A. Blom, B. Dahlbäck, B. Villoutreix, 2004, Molecular immunology.

Functions of human complement inhibitor C4b-binding protein in relation to its structure.

A. Blom, B. Dahlbäck, B. Villoutreix, 2004, Archivum immunologiae et therapiae experimentalis.

Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus

B. Dahlbäck, A. Bengtsson, A. Jönsen, 2019, Arthritis Research & Therapy.

Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes

Adam Linder, Per Åkesson, B. Dahlbäck, 2012, Critical Care.

Characterization of apoM in normal and genetically modified mice Published, JLR Papers in Press, April 21, 2004. DOI 10.1194/jlr.M300451-JLR200

B. Dahlbäck, L. Nielsen, Kirsten Faber, 2004, Journal of Lipid Research.

Factor V Q506 Mutation (Activated Protein C Resistance) Associated with Reduced Intrapartum Blood Loss – a Possible Evolutionary Selection Mechanism

K. Maršál, B. Dahlbäck, P. Svensson, 1998, Thrombosis and Haemostasis.

Vitamin K–Dependent Protein S: Beyond the Protein C Pathway

B. Dahlbäck, 2017, Seminars in Thrombosis and Hemostasis.

Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b.

C. Smith, B. Dahlbäck, H. Müller-Eberhard, 1983, Proceedings of the National Academy of Sciences of the United States of America.

disorders Advances in understanding pathogenic mechanisms of thrombophilic

B. Dahlbäck, 2008 .

Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis

P. Carmeliet, L. Beckers, B. Dahlbäck, 2008, The Journal of pathology.

Polystyrene nanoparticles affecting blood coagulation.

Sara Linse, B. Dahlbäck, S. Linse, 2012, Nanomedicine : nanotechnology, biology, and medicine.

G ENETIC LOSS OF G AS 6 INDUCES P LAQUE S TABILITY IN EXPERIMENTAL A THEROSCLEROSIS

Linda, Beckers, P. Carmeliet, 2014 .

Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway: Novel Insights Into Structure–Function Relationships and Molecular Recognition

B. Dahlbäck, B. Villoutreix, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes

B. Dahlbäck, P. Åkesson, A. Linder, 2010, Critical care.

The First Laminin G-Type Domain in the SHBG-Like Region of Protein S Contains Residues Essential for Activation of the Receptor Tyrosine Kinase Sky

B. Dahlbäck, P. G. D. Frutos, P. Evenäs, 2000, Biological chemistry.

Anticoagulant factor V and thrombosis risk

B. Dahlbäck, 2004 .

Classic Thrombophilias and Thrombotic Risk Among Middle‐Aged and Older Adults: A Population‐Based Cohort Study

O. Melander, G. Engström, B. Dahlbäck, 2022, Journal of the American Heart Association.

Protein unfolding allow use of commercial antibodies in an apolipoprotein M sandwich ELISA

B. Dahlbäck, C. Christoffersen, L. Nielsen, 2015 .

endothelial cells, platelets and leukocytes GAS6 promotes inflammation by enhancing interactions between

P. Carmeliet, B. Dahlbäck, L. Moons, 2013 .

Screening the molecular surface of human anticoagulant protein C: A search for interaction sites

Bruno O. Villoutreix, David G. Covell, Anna M. Blom, 2001, J. Comput. Aided Mol. Des..

Blood coagulation

B. Dahlbäck, Björn Dahlbäck, 2000, The Lancet.

The complement regulator C4b-binding protein analyzed by molecular modeling, bioinformatics and computer-aided experimental design.

A. Blom, B. Dahlbäck, B. Villoutreix, 1999, Immunopharmacology.

Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus.

B. Wolffenbuttel, B. Dahlbäck, L. Nielsen, 2010, Atherosclerosis.

Vitamin K-Dependent Protein S Localizing Complement Regulator C4b-Binding Protein to the Surface of Apoptotic Cells1

A. Blom, B. Dahlbäck, J. Webb, 2002, The Journal of Immunology.

Genetic and Phenotypic Variability between Families with Hereditary Protein S Deficiency

B. Dahlbäck, M. Laffan, S. Rezende, 2002, Thrombosis and Haemostasis.

Rapid Intracellular Degradation of a Truncated Mutant Protein S (Q522X)

B. Dahlbäck, H. Saito, T. Yamazaki, 2002, Thrombosis and Haemostasis.

Protein S Thr103Asn Mutation Associated with Type II Deficiency Reproduced In Vitro and Functionally Characterised

B. Dahlbäck, T. Giri, P. D. de Frutos, 2000, Thrombosis and Haemostasis.

Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors.

B. Dahlbäck, N. Sala, T. Yamazaki, 2000, Blood.

CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.

A. Blom, B. Dahlbäck, L. Kask, 2003, Molecular immunology.

The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function.

B. Dahlbäck, A. Hillarp, Y. Härdig, 1997, The Biochemical journal.

Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.

G. Watts, B. Dahlbäck, L. Nielsen, 2010, Atherosclerosis.

Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M Published, JLR Papers in Press, May 24, 2007.

B. Dahlbäck, Björn Dahlbäck, J. Ahnström, 2007, Journal of Lipid Research.

A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: From biostructural pathology to specie

Bruno O. Villoutreix, Björn Dahlbäck, Olle Teleman, 1997, J. Comput. Aided Mol. Des..

Activated protein C resistance: from phenotype to genotype and clinical practice.

B. Dahlbäck, Bengt Zöller, A. Hillarp, 1995, Blood reviews.

Familial hypercholesterolaemia: cholesterol efflux and coronary disease

E. Sijbrands, B. Dahlbäck, C. Pullinger, 2016, European journal of clinical investigation.

Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism

B. Dahlbäck, J. Sundquist, K. Sundquist, 2016, Thrombosis and Haemostasis.

Activated protein C resistance – in the absence of factor V Leiden – and pregnancy

B. Dahlbäck, P. Svensson, P. Lindqvist, 2006, Journal of thrombosis and haemostasis : JTH.

Association of vitamin K-dependent coagulation proteins and C4b binding protein with triglyceride-rich lipoproteins of human plasma.

B. Dahlbäck, A. Nilsson, N. Xu, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Serum Amyloid P Component Binding to C4b-binding Protein (*)

B. Dahlbäck, P. D. de Frutos, Y. Härdig, 1995, The Journal of Biological Chemistry.

Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.

B. Dahlbäck, P. García de Frutos, 1994, Journal of immunology.

coagulant response to Escherichia coli Role of free protein S and C4b binding protein in regulating the

C. Esmon, B. Dahlbäck, A. Chang, 2011 .

C4b-binding Protein and Factor H Compensate for the Loss of Membrane-bound Complement Inhibitors to Protect Apoptotic Cells against Excessive Complement Attack*

A. Blom, L. Trouw, B. Dahlbäck, 2007, Journal of Biological Chemistry.

Probing the activation of protein C by the thrombin‐thrombomodulin complex using structural analysis, site‐directed mutagenesis, and computer modeling

B. Dahlbäck, B. Villoutreix, J. Morser, 1999, Proteins.

In Vitro Characterisation of Two Naturally Occurring Mutations in the Thrombin-sensitive Region of Anticoagulant Protein S

B. Dahlbäck, B. Villoutreix, T. Yamazaki, 1999, Thrombosis and Haemostasis.

Analytical Considerations for Free Protein S Assays in Protein S Deficiency

B. Dahlbäck, A. Hillarp, K. Persson, 2001, Thrombosis and Haemostasis.

A New Direct, Fast and Quantitative Enzyme-linked Ligandsorbent Assay for Measurement of Free Protein S Antigen

B. Dahlbäck, Bengt Zöller, A. Hillarp, 1998, Thrombosis and Haemostasis.

Thrombophilia: the discovery of activated protein C resistance.

B. Dahlbäck, 1995, Advances in genetics.

A hydrophobic patch (PLVIVG; 1481–1486) in the B‐domain of factor V‐short is crucial for its synergistic TFPIα‐cofactor activity with protein S and for the formation of the FXa‐inhibitory complex comprising FV‐short, TFPIα, and protein S

B. Dahlbäck, S. Tran, 2022, Journal of thrombosis and haemostasis : JTH.

Factor V‐short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors

B. Dahlbäck, S. Tran, L. J. Guo, 2017, Research and practice in thrombosis and haemostasis.

C4b-binding protein: a forgotten factor in thrombosis and hemostasis.

B. Dahlbäck, 2011, Seminars in thrombosis and hemostasis.

Dependence on Vitamin K-dependent Protein S for Eukaryotic Cell Secretion of the β-Chain of C4b-binding Protein*

B. Dahlbäck, S. Carlsson, 2010, The Journal of Biological Chemistry.

Assembly of protein S and C4b-binding protein on membranes.

B. Dahlbäck, G. Nelsestuen, A. Hillarp, 1990, The Journal of biological chemistry.

Activated protein C cofactor function of protein S : a critical role for Asp 95 in the EGF 1-like domain

B. Dahlbäck, S. Rezende, D. Lane, 2010 .

C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae.

A. Blom, B. Dahlbäck, S. Ram, 2001, International immunopharmacology.

Binding of C4b-Binding Protein to Porin

A. Blom, B. Dahlbäck, S. Ram, 2001, The Journal of experimental medicine.

Binding of C4b-binding protein: A molecular mechanism of serum resistance of Neisseria gonorrhoeae

A. Blom, B. Dahlbäck, S. Ram, 2001 .

Binding of C 4 b-binding protein : A molecular mechanism of serum resistance of Neisseria gonorrhoeae

A. Blom, B. Dahlbäck, S. Ram, 2001 .

IIB von W illebr and' s disease : mutations and clinical presentation in nine families Denmark, Germany and Sweden

B. Dahlbäck, H. Lenk, E. Scheibel, 1992 .

phenotypic heterogeneity Protein S secretion differences of missense mutants account for

B. Dahlbäck, Y. Espinosa-Parrilla, N. Sala, 2013 .

Molecular recognition in the protein C anticoagulant pathway

B. Dahlbäck, B. Villoutreix, B O Villoutreix, 2003, Journal of thrombosis and haemostasis : JTH.

Surface of Apoptotic Cells Complement Regulator C 4 b-Binding Protein Vitamin K-Dependent Protein S Localizing

A. Blom, B. Dahlbäck, J. Webb, 2002 .

Localization of a Hydrophobic Binding Site for Anticoagulant Protein S on the β-Chain of Complement Regulator C4b-binding Protein*

A. Blom, B. Dahlbäck, B. Villoutreix, 2001, The Journal of Biological Chemistry.

The C4b-binding protein-protein S interaction is hydrophobic in nature.

D. Covell, A. Wallqvist, A. Blom, 1998, Biochimica et biophysica acta.

Anionic Phospholipids Lose Their Procoagulant Properties When Incorporated into High Density Lipoproteins*

B. Dahlbäck, M. Jauhiainen, C. Ehnholm, 2009, Journal of Biological Chemistry.

Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.

D. Milewicz, B. Dahlbäck, L. Vincent, 2013, The Journal of clinical investigation.

Multifunctional Specificity of the Protein C/Activated Protein C Gla Domain*

B. Dahlbäck, D. Lane, C. Razzari, 2006, Journal of Biological Chemistry.

Factor V and protein S as cofactors to activated protein C.

B. Dahlbäck, 1997, Haematologica.

C1‐TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration

B. Dahlbäck, Filiz Ibraimi, S. Hafizi, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Amino-terminal Module of the C4b-binding Protein β-Chain Contains the Protein S-binding Site*

B. Dahlbäck, Y. Härdig, 1996, The Journal of Biological Chemistry.

Protein S binding in relation to the subunit composition of human C4b‐binding protein

B. Dahlbäck, A. Hillarp, M. Hessing, 1989, FEBS letters.

Inhibition of human vitamin-K-dependent protein-S-cofactor activity by a monoclonal antibody specific for a Ca2+-dependent epitope.

B. Dahlbäck, J. Malm, U. Persson, 1987, European journal of biochemistry.

Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms.

B. Dahlbäck, A. Gottsäter, B. Lindblad, 2010, Clinical biochemistry.

Plasma Concentrations of Growth Arrest Specific Protein 6 and the Soluble Form of its Tyrosine Kinase Receptor Axl in Abdominal Aortic Aneurysms

B. Dahlbäck, A. Gottsäter, B. Lindblad, 2009 .

Results Gas 6 is Present in Plasma but Undetectable in Human Platelets

B. Dahlbäck, K. Hansson, I. Balogh, 2005 .

Coagulation and inflammation—close allies in health and disease

B. Dahlbäck, 2011, Seminars in Immunopathology.

Urinary apolipoprotein M as a biomarker of acute kidney injury in children undergoing heart surgery.

G. Navis, B. Dahlbäck, L. Nielsen, 2016, Biomarkers in medicine.

The C4b-binding Protein-Protein S Complex Inhibits the Phagocytosis of Apoptotic Cells*

A. Blom, L. Trouw, B. Dahlbäck, 2004, Journal of Biological Chemistry.

Resistance to Activated Protein C, the Arg506 to Gin Mutation in the Factor V Gene, and Venous Thrombosis

B. Dahlbäck, 1995, Thrombosis and Haemostasis.

Complement Regulator C 4 b-Binding Protein and the Human Neisseria gonorrhoeae A Novel Interaction Between Type IV Pili of Lindahl

A. Blom, G. Lindahl, B. Dahlbäck, 2001 .

Diagnosing protein S deficiency: analytical considerations.

B. Dahlbäck, A. Hillarp, Kristina E. M. Persson, 2003, Clinical laboratory.

Proposed structural models of the prothrombinase (FXa–FVa) complex

Bruno O Villoutreix, Ludovic Autin, B. Dahlbäck, 2006, Proteins.

The importance of the protein C system in the pathogenesis of venous thrombosis

B. Dahlbäck, 2005, Hematology.

Cloning of cDNA coding for the beta chain of human complement component C4b-binding protein: sequence homology with the alpha chain.

B. Dahlbäck, A. Hillarp, Andreas Hillarp, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Protein C, a Regulator of Prothrombin Activation

P. Fernlund, B. Dahlbäck, Koji Suzuki, 1982 .

Mutations in α-Chain of C4BP That Selectively Affect Its Factor I Cofactor Function*

A. Blom, B. Dahlbäck, B. Villoutreix, 2003, Journal of Biological Chemistry.

Structural stability and heat‐induced conformational change of two complement inhibitors: C4b‐binding protein and factor H

A. Blom, B. Dahlbäck, L. Kask, 2004, Protein science : a publication of the Protein Society.

Low FV beneficial in FVFVIII deficiency?

B. Dahlbäck, 2019, Blood.

The Role of Thrombin Exosites I and II in the Activation of Human Coagulation Factor V*

B. Dahlbäck, G. Nicolaes, J. Rosing, 2007, Journal of Biological Chemistry.

Molecular cloning of rat C4b binding protein alpha- and beta-chains: structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins.

B. Dahlbäck, A. Thern, A. Hillarp, 1997, Journal of immunology.

A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP.

E. Johnsson, G. Lindahl, B. Dahlbäck, 1996, Journal of Immunology.

Molecular Model for the C-type Lectin Domain of Human Thrombomodulin

B. Dahlbäck, B. Villoutreix, 1998 .

Inhibition of complement components C3 and C4 by cadralazine and its active metabolite

B. Dahlbäck, A. Hanson, M. Andersson, 2004, European Journal of Clinical Pharmacology.

Inherited resistance to activated protein C, a major basis of venous thrombosis, is caused by deficient anticoagulant cofactor function of factor V.

B. Dahlbäck, 1995, Haematologica.

Human C 4 b-Binding Protein Has Overlapping , But Not Identical , Binding Sites for C 4 b and Streptococcal M Proteins 1

A. Blom, K. Berggård, G. Lindahl, 2000 .

Small and large PROS1 deletions but no other types of rearrangements detected in patients with protein S deficiency

B. Dahlbäck, C. Halldén, A. Dahlén, 2012, Thrombosis and Haemostasis.

A new model for coagulation factor V suggesting a unique mechanism of activation.

B. Dahlbäck, 1988, Scandinavian journal of clinical and laboratory investigation. Supplementum.

Structural prediction and analysis of endothelial cell protein C/activated protein C receptor.

A. Blom, B. Dahlbäck, B. Villoutreix, 1999, Protein engineering.

Human C4b-Binding Protein Has Overlapping, But Not Identical, Binding Sites for C4b and Streptococcal M Proteins1

A. Blom, K. Berggård, G. Lindahl, 2000, The Journal of Immunology.

Novel subunit in C4b-binding protein required for protein S binding.

B. Dahlbäck, A. Hillarp, 1988, The Journal of biological chemistry.

Enhanced Rate of Cleavage at Arg-306 and Arg-506 in Coagulation Factor Va by Gla Domain-mutated Human-activated Protein C*

B. Dahlbäck, Björn Dahlbäck, Yong-Hui Sun, 2004, Journal of Biological Chemistry.

R2 haplotype Molecular basis of quantitative factor V deficiency associated with factor V

B. Dahlbäck, G. Nicolaes, T. Yamazaki, 2013 .

Bordetella pertussis binds to human C4b‐binding protein (C4BP) at a site similar to that used by the natural ligand C4b

A. Blom, K. Berggård, G. Lindahl, 2001, European journal of immunology.

Human C4BP binds to the hypervariable N-terminal region of many members in the streptococcal M protein family.

E. Johnsson, G. Lindahl, B. Dahlbäck, 1997, Advances in experimental medicine and biology.

Rabbit Plasma, unlike Its Human Counterpart, Contains no Complex between Protein S and C4b-Binding Protein

B. Dahlbäck, Xuhua He, 1994, Thrombosis and Haemostasis.

The protein S-binding site localized to the central core of C4b-binding protein.

B. Dahlbäck, A. Hillarp, 1987, The Journal of biological chemistry.

Degradation of human complement component C4b in the presence of the C4b-binding protein-protein S complex.

B. Dahlbäck, B. Dahlback, B. Hildebrand, 1983, The Biochemical journal.

Co‐segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1

B. Dahlbäck, A. Johansson, C. Halldén, 2004, Journal of thrombosis and haemostasis : JTH.

Prevention of thrombosis following deep arterial injury in rats by bovine activated protein C requiring co-administration of bovine protein S

K. Malm, B. Dahlbäck, B. Arnljots, 2003, Thrombosis and Haemostasis.

Successful hunt for quantitative trait locus in thrombophilia.

B. Dahlbäck, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein.

A. Blom, B. Dahlbäck, L. Kask, 2002, Biochemistry.

Calcium binding of bovine protein S. Effect of thrombin cleavage and removal of the gamma-carboxyglutamic acid-containing region.

B. Dahlbäck, A. Holmgren, J. Stenflo, 1986, The Journal of biological chemistry.

The binding of protein S and the protein S–C4BP complex to neutrophils is apoptosis dependent

A. Blom, B. Dahlbäck, J. Webb, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Coagulation and inflammation—close allies in health and disease

B. Dahlbäck, 2011, Seminars in Immunopathology.

The role of phospholipid transfer protein in lipoprotein‐mediated neutralization of the procoagulant effect of anionic liposomes

B. Dahlbäck, M. Jauhiainen, C. Ehnholm, 2010, Journal of thrombosis and haemostasis : JTH.

Characterization of recombinant epidermal growth factor (EGF)-like modules from vitamin-K-dependent protein S expressed in Spodoptera cells--the cofactor activity depends on the N-terminal EGF module in human protein S.

B. Dahlbäck, T. Drakenberg, J. Stenflo, 1998, European journal of biochemistry.

PROTEIN C, PROTEIN S AND THE FIBRINOLYTIC SYSTEM IN PATIENTS WITH A HISTORY OF THROMBOSIS

B. Dahlbäck, J. Malm, M. Laurell, 1987, Thrombosis and Haemostasis.

The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels

B. Dahlbäck, H. Axelson, B. Ljungberg, 2015, PloS one.

Vitamin K-dependent protein S in Leydig cells of human testis.

B. Dahlbäck, J. Malm, A. Bjartell, 1994, The Biochemical journal.

Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S

B. Dahlbäck, P. G. D. Frutos, B. Zöller, 1994 .

Molecular Models for the two Discoidin Domains of Human Blood Coagulation Factor V

P. Bucher, K. Hofmann, B. Dahlbäck, 1998 .

Gas6 fueling tumor-mediated thrombosis.

B. Dahlbäck, Kaisa E. Happonen, 2016, Blood.

Dr. Dahlbäck’s Response to the Letter by Dr. Keeling - Factor V: Q506 and a Negative APC-Resistance Test - Modified APC-Resistance Test Offers Increased Sensitivity and Specificity for the FV: Q506 Allele

B. Dahlbäck, 1995, Thrombosis and Haemostasis.

ATP level of a starving surface-bound and free-living marine Vibrio sp.

S. Kjelleberg, B. Dahlbäck, 1984 .

Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membrane.

B. Dahlbäck, B. Villoutreix, O. Sperandio, 2010, Biochemical and biophysical research communications.

cDNA structure of rabbit C4b-binding protein alpha-chain. Preserved sequence motive in complement regulatory protein modules which bind C4b.

B. Dahlbäck, P. García de Frutos, P. G. D. Frutos, 1995, Biochimica et biophysica acta.

Human genes for the alpha and beta chains of complement C4b-binding protein are closely linked in a head-to-tail arrangement.

B. Dahlbäck, S. Rodríguez de Córdoba, S. R. Córdoba, 1990, Proceedings of the National Academy of Sciences of the United States of America.

The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.

D. Lindgren, B. Dahlbäck, H. Axelson, 2015 .

The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma

D. Lindgren, B. Dahlbäck, H. Axelson, 2015 .

The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.

D. Lindgren, B. Dahlbäck, H. Axelson, 2015 .

Mouse ApoM displays an unprecedented seven-stranded lipocalin fold: folding decoy or alternative native fold?

B. Dahlbäck, Y. Muller, H. Sticht, 2010, Journal of molecular biology.

Polystyrene nanoparticles affecting blood coagulation.

B. Dahlbäck, S. Linse, T. Cedervall, 2012, Nanomedicine : nanotechnology, biology, and medicine.

Identification of the MMRN1 Binding Region within the C2 Domain of Human Factor V*

B. Dahlbäck, G. Nicolaes, M. Quinn-Allen, 2004, Journal of Biological Chemistry.

Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism.

B. Dahlbäck, 1995, Blood.

High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.

B. Dahlbäck, Bengt Zöller, J. Nilsson, 1996, Thrombosis research.

Thrombophilia: the discovery of activated protein C resistance.

B. Dahlbäck, 1995, Advances in genetics.

Advances in understanding pathogenic mechanisms of thrombophilic disorders.

B. Dahlbäck, 2008, Blood.

Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.

B. Dahlbäck, E. Norström, Sofia Somajo, 2014, Thrombosis research.

Localization of thrombin cleavage sites in the amino-terminal region of bovine protein S.

B. Dahlbäck, J. Stenflo, Å. Lundwall, 1986, The Journal of biological chemistry.

Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain

B. Dahlbäck, S. Rezende, D. Lane, 2010, Blood.

Functional properties of recombinant factor V mutated in a potential calcium-binding site.

B. Dahlbäck, B. Villoutreix, G. Nicolaes, 2004, Biochemistry.

Treating hemophilia by targeting protein S?

B. Dahlbäck, 2018, Blood.

Genetic polymorphism in a region of the vWF pseudogene corresponding to exon 28 of the vWF gene

B. Dahlbäck, L. Holmberg, A. Kristoffersson, 1992, European journal of haematology.

Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.

B. Dahlbäck, Maria F. Gomez, J. Swinny, 2010, The international journal of biochemistry & cell biology.

TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

B. Dahlbäck, S. Rezende, D. Lane, 2014, Blood.

Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.

B. Dahlbäck, 1997, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.